Albert D. Mason Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,176
Closed -$209K 134
2025
Q4
$209K Hold
2,176
0.14% 126
2025
Q3
$207K Buy
+2,176
New +$200K 0.13% 132
2024
Q1
Sell
-2,464
Closed -$203K 155
2023
Q4
$203K Buy
+2,464
New +$188K 0.13% 144
2023
Q3
Sell
-2,464
Closed -$217K 155
2023
Q2
$217K Buy
+2,464
New +$212K 0.15% 140
2022
Q4
Sell
-2,564
Closed -$207K 154
2022
Q3
$207K Hold
2,564
0.17% 137
2022
Q2
$230K Hold
2,564
0.17% 134
2022
Q1
$284K Buy
+2,564
New +$271K 0.18% 135

Other funds holding MDT

Albert D. Mason Inc's MDT Position: Q1 2026 in Review

Albert D. Mason Inc sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,176 shares — an estimated $209K sold.

Albert D. Mason Inc first reported a position in MDT in Q1 2022 and held it in 7 quarters. The position peaked at $284K in Q1 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Albert D. Mason Inc reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Albert D. Mason Inc sold 2,176 Medtronic shares in Q1 2026, an estimated $209K.
  • Albert D. Mason Inc first reported a position in Medtronic in Q1 2022 and held it in 7 quarters.
  • Albert D. Mason Inc's Medtronic position peaked at $284K in Q1 2022.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Albert D. Mason Inc's 13F filing for Q1 2026, filed 15 Apr 2026.